000 01516 a2200421 4500
005 20250515201805.0
264 0 _c20100520
008 201005s 0 0 eng d
022 _a1421-9867
024 7 _a10.1159/000236025
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan der Velden, A W
245 0 0 _aPharmacological dependency in chronic treatment of gastroesophageal reflux disease: a randomized controlled clinical trial.
_h[electronic resource]
260 _bDigestion
_c2010
300 _a43-52 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _a2-Pyridinylmethylsulfinylbenzimidazoles
_xadministration & dosage
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aGastroesophageal Reflux
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPantoprazole
650 0 4 _aProton Pump Inhibitors
_xadministration & dosage
650 0 4 _aQuality of Life
650 0 4 _aSubstance-Related Disorders
_xepidemiology
700 1 _ade Wit, N J
700 1 _aQuartero, A O
700 1 _aGrobbee, D E
700 1 _aNumans, M E
773 0 _tDigestion
_gvol. 81
_gno. 1
_gp. 43-52
856 4 0 _uhttps://doi.org/10.1159/000236025
_zAvailable from publisher's website
999 _c19409758
_d19409758